HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Buscaglia, C. Articles by Schat, K. A. Search for Related Content PubMed PubMed Citation Articles by Buscaglia, C. Articles by Schat, K. A. Agricola Articles by Buscaglia, C. Articles by Schat, K. A.

Effect of Immunocompetence on the Establishment and Maintenance of Latency with Marek's Disease Herpesvirus

Department of Avian and Aquatic Animal Medicine, New York State College of Veterinary Medicine, Cornell University, Ithaca, New York 14853, U.S.A.

Marek's disease virus (MDV) infections normally have an early cytolytic phase in lymphoid organs at 3 to 6 days post-infection followed by a period of latent infection. Little is known about the mechanisms that govern latency with herpesvirus infections, including Marek's disease (MD). To investigate the importance of immunocompetence for either the establishment or the maintenance of latency in MD, immunosuppressive treatments were applied prior to infection with MDV or after latency was established. These included cyclosporin (Cs) or betamethasone (BM) treatments, neonatal thymectomy plus cyclophosphamide treatment (Tx/Cy), and infection at a young age before full competence. The effect of all the treatments was determined by examining tissues and spleen cells for evidence of virus replication before and after cultivation in vitro. Induced (Cs or Tx/Cy treatments) or natural (infection at a young age) incompetence resulted in prolonged and more widespread early cytolytic infection. Immunosuppression by Cs after latency had developed resulted in a reappearance of cytolytic infection in the spleen and it enhanced the cytolytic infection in the thymus and the bursa of Fabricius. After immunosuppression with Cs, cytolytic infection was found mostly in T cells, although many of the virus-positive cells did not have markers for either T cells or B cells. Immunosuppression by BM after latency had developed also resulted in the reappearance of cytolytic infection in the spleen but only at a very low level. These results suggest that immunocompetence is required for the establishment and maintenance of latency.

Keywords: Marek's disease, herpesviruses, immunosuppression

Received 20 July 1987; accepted 26 January 1987.

This article has been cited by other articles:

				S. J. Baigent, L. P. Smith, R. J. W. Currie, and V. K. Nair Replication kinetics of Marek's disease vaccine virus in feathers and lymphoid tissues using PCR and virus isolation J. Gen. Virol., November 1, 2005; 86(11): 2989 - 2998. [Abstract] [Full Text] [PDF]

				A. D. Barrow, S. C. Burgess, S. J. Baigent, K. Howes, and V. K. Nair Infection of macrophages by a lymphotropic herpesvirus: a new tropism for Marek's disease virus J. Gen. Virol., October 1, 2003; 84(10): 2635 - 2645. [Abstract] [Full Text] [PDF]

				M. S. Parcells, R. L. Dienglewicz, A. S. Anderson, and R. W. Morgan Recombinant Marek's Disease Virus (MDV)-Derived Lymphoblastoid Cell Lines: Regulation of a Marker Gene within the Context of the MDV Genome J. Virol., February 1, 1999; 73(2): 1362 - 1373. [Abstract] [Full Text]